INSPIRE MEDICAL SYSTEMS INC (INSP)
US4577301090 - Common Stock
Overall INSP gets a fundamental rating of 6 out of 10. We evaluated INSP against 188 industry peers in the Health Care Equipment & Supplies industry. While INSP has a great health rating, its profitability is only average at the moment. INSP is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make INSP suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
In the past year INSP had a positive cash flow from operations.
In the past 5 years INSP always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
INSP has a better Return On Assets (4.15%) than 80.21% of its industry peers.
INSP has a Return On Equity of 4.74%. This is in the better half of the industry: INSP outperforms 75.94% of its industry peers.
With a decent Return On Invested Capital value of 1.48%, INSP is doing good in the industry, outperforming 70.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.15% | ||
| ROE | 4.74% | ||
| ROIC | 1.48% |
ROA(3y)-8.44%
ROA(5y)-12.79%
ROE(3y)-10.36%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 4.37%, INSP is doing good in the industry, outperforming 76.47% of the companies in the same industry.
Looking at the Operating Margin, with a value of 1.79%, INSP is in the better half of the industry, outperforming 67.38% of the companies in the same industry.
INSP's Gross Margin of 84.77% is amongst the best of the industry. INSP outperforms 95.72% of its industry peers.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.79% | ||
| PM (TTM) | 4.37% | ||
| GM | 84.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5Y1.1%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
INSP has more shares outstanding than it did 1 year ago.
INSP has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
INSP has an Altman-Z score of 32.41. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
INSP has a Altman-Z score of 32.41. This is amongst the best in the industry. INSP outperforms 97.33% of its industry peers.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 32.41 |
ROIC/WACC0.16
WACC9.08%
2.3 Liquidity
INSP has a Current Ratio of 7.84. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP's Current ratio of 7.84 is amongst the best of the industry. INSP outperforms 86.63% of its industry peers.
INSP has a Quick Ratio of 6.94. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a better Quick ratio (6.94) than 86.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.84 | ||
| Quick Ratio | 6.94 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 194.69% over the past year.
INSP shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.51%.
Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 65.32% on average per year.
EPS 1Y (TTM)194.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%306.9%
Revenue 1Y (TTM)32.51%
Revenue growth 3Y75.59%
Revenue growth 5Y65.32%
Sales Q2Q%32.54%
3.2 Future
Based on estimates for the next years, INSP will show a very strong growth in Earnings Per Share. The EPS will grow by 54.65% on average per year.
The Revenue is expected to grow by 20.52% on average over the next years. This is a very strong growth
EPS Next Y282.55%
EPS Next 2Y117.34%
EPS Next 3Y84.95%
EPS Next 5Y54.65%
Revenue Next Year28.5%
Revenue Next 2Y23.87%
Revenue Next 3Y21.95%
Revenue Next 5Y20.52%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 161.62 indicates a quite expensive valuation of INSP.
INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 64.17% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.81, INSP is valued quite expensively.
INSP is valuated quite expensively with a Price/Forward Earnings ratio of 85.80.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than 66.31% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (23.56), we can say INSP is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 161.62 | ||
| Fwd PE | 85.8 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 63.64% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INSP is valued a bit cheaper than the industry average as 68.98% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 135.66 | ||
| EV/EBITDA | 245.23 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INSP's earnings are expected to grow with 84.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y117.34%
EPS Next 3Y84.95%
5. Dividend
5.1 Amount
INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INSPIRE MEDICAL SYSTEMS INC
NYSE:INSP (11/14/2024, 8:04:00 PM)
After market: 172.93 0 (0%)172.93
-9.25 (-5.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.18B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 161.62 | ||
| Fwd PE | 85.8 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.57
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.15% | ||
| ROE | 4.74% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.79% | ||
| PM (TTM) | 4.37% | ||
| GM | 84.77% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.84 | ||
| Quick Ratio | 6.94 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)194.69%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y282.55%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)32.51%
Revenue growth 3Y75.59%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y